Search

Prescription Drugs M-commerce App 'Yiyao' Wins RMB 135 Mln Series A+

Shanghai Pharmaceuticals, 3/18/16

Shanghai-based Dajiankang Yunshang Holding, operator of prescription drugs B2C m-commerce app Yiyao, has completed RMB RMB 135 mln Series A+ funding from Shanghai-based Yuepu Investment Center and Shanghai Shengtai Investment Management, according to a statement from Dajiankang Yunshang's parent company Shanghai Pharmaceuticals Holding (601607.SH). Read More